Development and validation of an interpretable prognostic model for bladder cancer based on lactylation associated genes using SHAP analysis

肿瘤科 医学 比例危险模型 单变量 内科学 膀胱癌 多元统计 队列 多元分析 预测模型 基因签名 特征选择 生存分析 基因表达谱 弗雷明翰风险评分 基因 转录组 总体生存率 单变量分析 计算生物学 免疫疗法 表观遗传学 疾病 存活率 队列研究 生物信息学 临床试验 癌症 肿瘤微环境
作者
Yongqi Wang,Xiao Yu
出处
期刊:Discover Oncology [Springer Nature]
卷期号:17 (1)
标识
DOI:10.1007/s12672-026-05111-z
摘要

OBJECTIVE: The high recurrence rate and poor clinical outcomes of bladder cancer (BLCA) underscore the urgent need for novel biomarkers to guide precision medicine. Focusing on lactylation-a novel epigenetic modification-this study aimed to construct and validate a prognostic model for BLCA based on lactylation-related genes. METHODS: Transcriptomic and clinical data were integrated from the Gene Expression Omnibus (GEO, GSE13507) and The Cancer Genome Atlas (TCGA-BLCA) cohorts. Core prognostic genes were identified, and a risk scoring model was constructed utilizing a stepwise framework comprising univariate Cox regression, Least Absolute Shrinkage and Selection Operator (LASSO) regression, and multivariate Cox regression. The SHapley Additive exPlanations (SHAP) algorithm was employed for personalized, interpretable survival predictions. Subsequently, the associations between the risk model and the tumor immune microenvironment (TIME), tumor mutational burden (TMB), and drug sensitivity were comprehensively evaluated. RESULTS: A 4-gene risk model comprising ATAD3A, MKI67, VWF, and CCL2 was ultimately established. The model demonstrated robust predictive efficacy in both the training cohort (1-, 3-, and 5-year AUCs of 0.802, 0.818, and 0.856, respectively) and the validation cohort (AUCs of 0.636, 0.601, and 0.627, respectively). Multivariate analysis confirmed that the risk score served as an independent prognostic factor. The SHAP analysis facilitated precise interpretability, bridging global feature importance with individual mortality risk. Immune infiltration profiling revealed a significant enrichment of M2 macrophages coupled with high CCL2 expression in the high-risk group. Furthermore, combined survival analysis indicated that patients with a "low TMB and high-risk" profile exhibited the poorest clinical outcomes. CONCLUSION: To our knowledge, this study is the first to establish a 4-gene lactylation-related prognostic model for BLCA integrating a LASSO-SHAP framework. This model not only provides precise, visualizable predictions for individualized survival risk but also elucidates the lactylation-driven immunosuppressive microenvironment in BLCA, offering crucial data support for the development of personalized immunotherapeutic and targeted strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kmkz发布了新的文献求助10
1秒前
1秒前
1秒前
2秒前
2秒前
AHMZI完成签到,获得积分10
2秒前
荣荣发布了新的文献求助10
2秒前
3秒前
Su发布了新的文献求助10
3秒前
打打的应助被zrf采纳,获得100
3秒前
molihuakai的应助被zdk采纳,获得10
3秒前
梦锡发布了新的文献求助10
3秒前
3秒前
zgmhemtt完成签到 ,获得积分10
3秒前
Song完成签到,获得积分10
4秒前
TTTTTT发布了新的文献求助10
4秒前
luyue9406的应助被nnn采纳,获得10
5秒前
今天发CNS了嘛完成签到,获得积分0
5秒前
仙人掌完成签到 ,获得积分10
6秒前
adu完成签到,获得积分10
6秒前
Mokwepa完成签到,获得积分20
6秒前
6秒前
小蘑菇的应助被贾文浩采纳,获得10
7秒前
Song发布了新的文献求助10
7秒前
7秒前
自由妙竹完成签到 ,获得积分10
7秒前
慕青的应助被科研通管家采纳,获得10
7秒前
华仔的应助被害怕的穆采纳,获得10
7秒前
Akim的应助被科研通管家采纳,获得10
7秒前
Maestro_S的应助被iQ采纳,获得10
7秒前
上官若男的应助被科研通管家采纳,获得10
7秒前
蓝天的应助被科研通管家采纳,获得10
8秒前
Owen的应助被xiaoyibabi采纳,获得30
8秒前
123564的应助被科研通管家采纳,获得10
8秒前
明理的帆布鞋完成签到,获得积分10
8秒前
SciGPT的应助被科研通管家采纳,获得10
8秒前
赘婿的应助被科研通管家采纳,获得10
8秒前
刘放发布了新的文献求助10
8秒前
小二郎的应助被科研通管家采纳,获得10
8秒前
123564的应助被科研通管家采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168144
求助须知:如何正确求助?哪些是违规求助? 9561199
关于积分的说明 21759542
捐赠科研通 7759434
什么是DOI,文献DOI怎么找? 3429948
关于科研通互助平台的介绍 2553742
邀请新用户注册赠送积分活动 2474463